Peripheral Nerve Stimulators Market by Product, Stimulating Feature, and Geography - Forecast and Analysis 2021-2025

The peripheral nerve stimulators market size has the potential to grow by USD 141.03 million during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 5.25%. 

This report provides a detailed analysis of the market by product (transcutaneous, percutaneous, and implantable), stimulating feature (PNS-TOF and PNS), geography (North America, Europe, Asia, and ROW), and key vendors. 

Market Overview

Browse TOC and LoE with selected illustrations and example pages of Peripheral Nerve Stimulators Market

 Request a FREE sample now!

Market Competitive Analysis

The report analyzes the market’s competitive landscape and offers information on several market vendors, including: 

 

• Abbott Laboratories
• Avanos Medical Inc.
• B. Braun Melsungen AG
• Bioness Inc.
• Boston Scientific Corp.
• Medtronic Plc
• PAJUNK GmbH Medical Technology
• SPR Therapeutics Inc.
• SunMed LLC
• Xavant Technology Pty Ltd.

 

The peripheral nerve stimulators market is fragmented and the vendors are deploying growth strategies such as R&D to compete in the market. Click here to uncover other successful business strategies deployed by the vendors. 

The market players also significantly leverage external market drivers such as high demand for peripheral nerve stimulators over oral medications to achieve growth opportunities. However, factors such as availability of alternatives will challenge the growth of the market participants. To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the peripheral nerve stimulators market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

This peripheral nerve stimulators market analysis report also provides detailed information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities. 

Peripheral Nerve Stimulators Market: Key Drivers and Trends

There is growing popularity of minimally invasive devices such as peripheral nerve stimulators over oral medications. Peripheral nerve stimulators reduce the use of narcotic drugs and relieve pain by providing target-specific treatment in patients.  Peripheral nerve stimulators implanted in patients do not affect their recreational activities.  Because of such advantages, patients have started preferring peripheral nerve stimulators over oral medications, augmenting the market's growth prospects

The market is witnessing the development of new generation wireless PNS devices that can be planted to the targeted peripheral nerves. These devices require no wire or bulky battery implants and allow physicians to monitor and program the device remotely.  Wireless PNS devices also eliminate the need for painful invasive procedures, thereby reducing healthcare expenses and hospital stays. Such benefits will increase the adoption of wireless PNS devices, subsequently driving market growth

 

Grab your Free Sample now to unlock further information on other key market drivers

Peripheral Nerve Stimulators Market: Segmentation by Geography

For more insights on the market share of various regions Request for a FREE sample now!

41% of the market’s growth will originate from North America during the forecast period. The US is one of the key markets for peripheral nerve stimulators market in North America. Market growth in this region will be slower than the growth of the market in Asia.

The strong prevalence of neurological disorders such as neuropathic pain and the increasing geriatric and obese population are the prime factors that will facilitate the peripheral nerve stimulators market growth in North America over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report. 

Peripheral Nerve Stimulators Market: Segmentation by Product

Request for a FREE sample and Get more information on the market contribution of various segments

Transcutaneous stimulators are non-invasive and can be used to treat both acute and chronic pain conditions such as fibromyalgia, neck pain, labor pain, and cancer pain. Benefits of transcutaneous peripheral nerve stimulators such as reduced cross-infection risk and low allergy incidence rates will fuel the preference for these stimulators in the coming years. Therefore the growth of the market segment is expected to be significant during the forecast period.

Fetch actionable market insights on post COVID-19 impact on each segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the peripheral nerve stimulators market size.

 

Request for a FREE sample

Peripheral Nerve Stimulators Market: Key Highlights of the Report for 2021-2025

• CAGR of the market during the forecast period 2021-2025
• Detailed information on factors that will drive peripheral nerve stimulators market growth during the next five years
• Precise estimation of the peripheral nerve stimulators market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the peripheral nerve stimulators industry across North America, Europe, Asia, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of peripheral nerve stimulators market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Peripheral Nerve Stimulators Market Scope
Report Coverage	Details
Page number	120
Base year	2020
Forecast period	2021-2025
Growth momentum & CAGR	Accelerate at a CAGR of 5%
Market growth 2021-2025	$ 141.03 million
Market structure	Fragmented
YoY growth (%)	4.85
Regional analysis	North America, Europe, Asia, and ROW
Performing market contribution	North America at 41%
Key consumer countries	US, Germany, UK, Japan, and France
Competitive landscape	Leading companies, competitive strategies, consumer engagement scope
Companies profiled	Abbott Laboratories, Avanos Medical Inc., B. Braun Melsungen AG, Bioness Inc., Boston Scientific Corp., Medtronic Plc, PAJUNK GmbH Medical Technology, SPR Therapeutics Inc., SunMed LLC, and Xavant Technology Pty Ltd.
Market Dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.